000403 Pacific Shuanglin Bio-pharmacy
- 22.66
- -0.58-2.50%
About Pacific Shuanglin Bio-pharmacy Company
The company was listed on the Shenzhen Stock Exchange with the approval of the China Securities Regulatory Commission on June 28, 1996. After some column changes, the company changed its name to its current name on March 30, 2021. The company's main business is research, development, production and sales of blood products. Main products: human blood albumin, human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, human immunoglobulin for tetanus, rabies immunoglobulin, human coagulation factor VIII, human fibrinogen, intravenous hepatitis B human immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human prothrombin complex, etc. The company won the honor of the Two Integrated Management System Assessment Class A Certificate and the Heilongjiang Digital (Intelligent) Demonstration Workshop; Guangdong Shuanglin won the Zhanjiang Water Saving Enterprise Award; the Dual Integrated Management System Assessment Class A Certificate; the Heilongjiang Digital (Intelligent) Demonstration Workshop; and the Zhanjiang Water Saving Enterprise Honor.
Company Profile
Company Executives
- Name
- Position
- Salary
- hao li
- Chairman, Directors, Chairman of the Strategy Committee, Audit Committee Member
- --
- shaolan fu
- Directors, Co-chairman, Strategy Committee Member
- 3.05M
- lihao liu
- Directors
- --
- lan ye
- Directors, Deputy General Manager, Nomination Committee Members
- 101.00K
- wenbin si
- Directors, Deputy General Manager, Strategy Committee Member
- 101.00K
- li yang
- Directors, Audit Committee Member
- 1.92M
- lei yan
- Directors, Deputy General Manager, Member of the Remuneration and Assessment Committee
- 1.61M
- xiaoying huang
- Directors, Deputy General Manager, Member of the Remuneration and Assessment Committee
- 101.00K
- jun liu
- Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
- 6.00K
- jun yin
- Independent Directors, Strategy Committee Member, Nomination Committee Members
- 18.60K
- wenqi wang
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- 18.60K
- jingang zhang
- Independent Directors, Strategy Committee Member, Chairman of the Nomination Committee
- 6.00K
- zuojun dong
- Independent Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee, Nomination Committee Members
- 100.00K
- yulin zhao
- Board Secretary
- --
- hui guo
- Chairman of the Supervisory Board, Auditors
- --
- yuli song
- Auditors
- --
- chao zuo
- Auditors
- --
- xiankui rong
- General Manager
- 669.00K
- qunge zhang
- Deputy General Manager
- --
- yehong wang
- Chief Financial Officer
- --
- yiliang wu
- Employee Supervisors
- 140.70K
- wei zheng
- Employee Supervisors
- 32.60K
Analysis
Price Target
No Data
No Data